Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-14

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' generic amlodipine and olmesartan medoxomil fixed-dose combination (ANDA 209591).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

ORIG AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)